14-21001111-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014579.4(SLC39A2):c.462T>A(p.His154Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H154Y) has been classified as Likely benign.
Frequency
Consequence
NM_014579.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC39A2 | NM_014579.4 | c.462T>A | p.His154Gln | missense_variant | 4/4 | ENST00000298681.5 | |
SLC39A2 | NM_001256588.2 | c.*199T>A | 3_prime_UTR_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC39A2 | ENST00000298681.5 | c.462T>A | p.His154Gln | missense_variant | 4/4 | 1 | NM_014579.4 | P1 | |
SLC39A2 | ENST00000554422.5 | c.*199T>A | 3_prime_UTR_variant | 4/4 | 1 | ||||
ENST00000647921.1 | n.398-1281A>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 151878Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251272Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135794
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461794Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727200
GnomAD4 genome AF: 0.000105 AC: 16AN: 151996Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.462T>A (p.H154Q) alteration is located in exon 4 (coding exon 4) of the SLC39A2 gene. This alteration results from a T to A substitution at nucleotide position 462, causing the histidine (H) at amino acid position 154 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at